Golimumab switch assessment in Rheumatoid Arthritis

• Research type

  Research Study

• Full title

  A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept (ENBREL®) or Adalimumab (HUMIRA®).

• IRAS ID

  22808

• Sponsor organisation

  Centocor BV

• Eudract number

  2009-010582-23

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  N/A

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  09/H0402/105

• Date of REC Opinion

  31 Dec 2009

• REC opinion

  Favourable Opinion